Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Pharmaceutical Preparations.
The next scheduled catalyst is Next quarterly earnings (projected) on October 21, 2026, a projected date rather than a confirmed one. There are 3 upcoming events on record.
Cash runway is approximately 13.1 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.
| Date | Event | Type | Phase |
|---|---|---|---|
| October 21, 2026 est. | Next quarterly earnings (projected) | Earnings | — |
| May 30, 2027 | A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma | Trial Milestone | Phase 2 |
| August 12, 2027 | Study of ACR-2316 in Specific Advanced Solid Tumors | Trial Milestone | Phase 1/Phase 2 |
Track ACRV alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open ACRV in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| August 12, 2026 | Quarterly results filed (8-K) | Earnings | — |
| June 17, 2026 | 8-K filed: Leadership change | Corporate | — |
| May 13, 2026 | Quarterly results filed (8-K) | Earnings | — |
| March 19, 2026 | Quarterly results filed (8-K) | Earnings | — |
| February 27, 2026 | 8-K filed: Reg FD disclosure | Filing | — |
| January 8, 2026 | Quarterly results filed (8-K) | Earnings | — |
| January 8, 2026 | 8-K filed: Reg FD disclosure | Filing | — |
| November 13, 2025 | Quarterly results filed (8-K) | Earnings | — |
| September 5, 2025 | 8-K filed: Reg FD disclosure | Filing | — |
| August 13, 2025 | Quarterly results filed (8-K) | Earnings | — |
| May 14, 2025 | Quarterly results filed (8-K) | Earnings | — |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.